CD4 and neoplasm: Notably, both the magnitude and the means of several CD8+ or CD4+ Teff cell responses against the single NM-neoAg peptide pools were higher in the subset of naive patients showing earlier stage tumor and who did not experience any neo-adjuvant chemotherapy before surgery, as compared with HDs (Fig. 4; Supplementary Fig. 6).